-- 据周二提交给孟买证券交易所（BSE）的文件显示，Auro Laboratories（BOM:530233）已收到欧洲药品质量管理局（EDQM）对其盐酸二甲双胍CEP文件的检验认证。 该公司股价在周三的交易中上涨近4%。 文件称，该认证确认其位于MIDC Tarapur的工厂符合欧盟良好生产规范（GMP）的要求。
Related Articles
Mining & Metals
Earnings Flash (SDE.TO) Spartan Delta Corp. Increased 2026 Guidance and Increase To Credit Facility
$SDE.TO
Asia
ValueMax Raises SG$24 Million Through Digital Securities Issuance
ValueMax (SGX:T6I) raised over SG$23.9 million through the issuance of digital securities on the SDXX platform, according to a Wednesday filing with the Singapore Exchange.The issuance will be listed on the SDXX platform on May 7, the filing added.
$SGX:T6I
Mining & Metals
Earnings Flash (ADEN.TO) ADENTRA Posted Q1 Adjusted EPS US$0.38 per Share, vs. FactSet Est of $0.31
$ADEN.TO